NCT01471340 A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) Status COMPLETED Phase PHASE4
NCT01470911 Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01470755 Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden Status COMPLETED Phase PHASE2
NCT01462617 Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 Status COMPLETED Phase PHASE1
NCT01462344 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old Status COMPLETED Phase PHASE4
NCT01460862 Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations Status WITHDRAWN Phase N/A
NCT01460511 Evaluation of Efficacy and Safety of E004 in Children With Asthma Status COMPLETED Phase PHASE3
NCT01458912 Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Status WITHDRAWN Phase PHASE2
NCT01458886 Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone Status WITHDRAWN Phase PHASE2
NCT01453881 Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation Status COMPLETED Phase PHASE3
NCT01453296 Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects Status COMPLETED Phase PHASE2
NCT01453023 Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study Status COMPLETED Phase PHASE2